• Arzneimittel Forsch · Jan 2011

    Randomized Controlled Trial

    Pharmacokinetics and bioequivalence study of two mosapride citrate formulations after single-dose administration in healthy Chinese male volunteers.

    • Jun Huang, Yuan Tian, Zun-Jian Zhang, Jinheng Li, and Xiaomei Cao.
    • [Key Laboratory of Drug Quality Control and Pharmacovigilance, P.R. (China Pharmaceutical University), Ministry of Education, Nanjing, P.R. China.
    • Arzneimittel Forsch. 2011 Jan 1; 61 (3): 167-72.

    AbstractThe pharmacokinetics and relative bioavailability/bioequivalence of two formulations of mosapride citrate (CAS 112885-42-4) were assessed in this study. The study was conducted in 20 healthy Chinese male volunteers according to an open, randomized, single-blind, 2-way crossover study design with a wash-out phase of 7 days. Blood samples for pharmacokinetic profiling were taken up to 12 h post-dose, and mosapride citrate plasma concentrations were determined by a validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. Based on the plasma concentration-time data of each individual during two periods, pharmacokinetic parameters, Cmax, AUCo-t,, AUCo-infinity, and t1/2, were calculated by applying non-compartmental analysis. Pharmacokinetic data for test and reference formulations were analyzed statistically to test for bioequivalence of the two formulations. After oral administration, the values of Cmax, Tmax, t1/2, AUCo-t, AUCo-infinity for test and reference formulations were 68.48 +/- 22.95 and 70.69 +/- 23.78 ng/mL, 0.46 +/- 0.20 and 0.49 +/- 0.21 h, 2.30 +/- 0.30 and 2.24 +/- 0.28 h, 161.17 +/- 52.75 and 171.37 +/- 59.02 ng x h/mL, 165.76 +/- 54.34 and 175.77 +/- 60.54 ng x h/mL, respectively. Both primary target parameters, AUCo-infinity and AUCo-t, were tested parametrically by analysis of variance (ANOVA). Relative bioavailabilities were 95.3 +/- 11.3% for AUCo-infinity and 95.2 +/- 11.3% for AUo-t. Bioequivalence between test and reference formulations was demonstrated for both parameters, AUJCo-infinity and AUCo-t. The 90% confidence intervals of the T/R-ratios of logarithmically transformed data were in the generally accepted range of 80-125%. That means that the test formulation is bioequivalent to the reference formulation of mosapride citrate.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…